(VIANEWS) – CAIRN HOMES PLC (C5H.IR), SANOFI (SAN.PA), SOCIETE GENERALE (GLE.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| CAIRN HOMES PLC (C5H.IR) | 4.14% | 2024-03-17 05:17:10 |
| SANOFI (SAN.PA) | 4.06% | 2024-03-17 04:02:04 |
| SOCIETE GENERALE (GLE.PA) | 4% | 2024-03-15 09:22:55 |
| AALBERTS NV (AALB.AS) | 2.6% | 2024-03-17 05:00:03 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. CAIRN HOMES PLC (C5H.IR)
4.14% Foward Dividend Yield
CAIRN HOMES PLC’s last close was €1.55, 1.28% under its 52-week high of €1.57. Intraday change was -0.26%.
Cairn Homes plc operates as a homebuilder in Ireland. It is involved in the development and sale of residential properties, as well as rental of properties. The company was incorporated in 2014 and is based in Dublin, Ireland.
Earnings Per Share
As for profitability, CAIRN HOMES PLC has a trailing twelve months EPS of €0.13.
PE Ratio
CAIRN HOMES PLC has a trailing twelve months price to earnings ratio of 11.77. Meaning, the purchaser of the share is investing €11.77 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.32%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.6%, now sitting on 666.81M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CAIRN HOMES PLC’s stock is considered to be oversold (<=20).
Volatility
CAIRN HOMES PLC’s last week, last month’s, and last quarter’s current intraday variation average was 0.67%, 0.19%, and 1.10%.
CAIRN HOMES PLC’s highest amplitude of average volatility was 1.20% (last week), 1.12% (last month), and 1.10% (last quarter).
More news about CAIRN HOMES PLC.
2. SANOFI (SAN.PA)
4.06% Foward Dividend Yield
SANOFI’s last close was €88.20, 16.14% under its 52-week high of €105.18. Intraday change was 0.28%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 20.57. Meaning, the purchaser of the share is investing €20.57 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.27%.
Volume
Today’s last reported volume for SANOFI is 1075720 which is 15.59% below its average volume of 1274430.
Sales Growth
SANOFI’s sales growth for the current quarter is 4%.
More news about SANOFI.
3. SOCIETE GENERALE (GLE.PA)
4% Foward Dividend Yield
SOCIETE GENERALE’s last close was €23.73, 14.33% under its 52-week high of €27.70. Intraday change was 0.75%.
Société Générale Société anonyme provides banking and financial services to individuals, businesses, and institutional investors in Europe and internationally. It operates through French Retail Banking, International Retail Banking & Financial Services, and Global Banking and Investor Solutions. It offers retail banking services, such as consumer credit, vehicle leasing and fleet management, online banking, wealth management services, and equipment and vendor finance under the Societe Generale, Credit du Nord, and Boursorama brand names; and insurance products, including home, vehicle, family, health, and mortgage insurance. The company also provides corporate and investment banking, securities, business consulting, consumer finance, advisory and financing, and asset management and private banking services. In addition, it offers brokerage, cash management, payment, factoring, export financing, and supply chain financing services. Société Générale Société anonyme was incorporated in 1864 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SOCIETE GENERALE has a trailing twelve months EPS of €2.17.
PE Ratio
SOCIETE GENERALE has a trailing twelve months price to earnings ratio of 10.9. Meaning, the purchaser of the share is investing €10.9 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.63%.
More news about SOCIETE GENERALE.
4. AALBERTS NV (AALB.AS)
2.6% Foward Dividend Yield
AALBERTS NV’s last close was €43.53, 3.48% below its 52-week high of €45.10. Intraday change was -0.66%.
Aalberts N.V. engineers mission-critical technologies. It operates in two segments: Building Technology and Industrial Technology. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.
Earnings Per Share
As for profitability, AALBERTS NV has a trailing twelve months EPS of €2.85.
PE Ratio
AALBERTS NV has a trailing twelve months price to earnings ratio of 15.21. Meaning, the purchaser of the share is investing €15.21 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.
Volume
Today’s last reported volume for AALBERTS NV is 33843 which is 79.1% below its average volume of 161971.
Yearly Top and Bottom Value
AALBERTS NV’s stock is valued at €43.34 at 11:50 EST, below its 52-week high of €45.10 and way above its 52-week low of €28.83.
Sales Growth
AALBERTS NV’s sales growth for the current quarter is negative 1.4%.
More news about AALBERTS NV.
